Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Public ClinicalTrials.gov record NCT00883129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Study identification
- NCT ID
- NCT00883129
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Michael Roth
- Other
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Interventions
- Mycophenolate mofetil Drug
- Cyclophosphamide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2009
- Primary completion
- Dec 31, 2014
- Completion
- Oct 31, 2015
- Last update posted
- Feb 9, 2017
2009 – 2015
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90095 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| Georgetown University School of Medicine | Washington D.C. | District of Columbia | 20057 | — |
| Feinberg School of Medicine, Northwestern University | Chicago | Illinois | 60611 | — |
| University of Illinois at Chicago, College of Medicine | Chicago | Illinois | 60612 | — |
| Johns Hopkins University School of Medicine | Baltimore | Maryland | 21205 | — |
| Boston University School of Medicine | Boston | Massachusetts | 02118 | — |
| University of Michigan Medical School | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota | Minneapolis | Minnesota | 55454 | — |
| University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08854 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Texas Medical School at Houston | Houston | Texas | 77225 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00883129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00883129 live on ClinicalTrials.gov.